Active Member
10 Years
Shanghai Yaxin Biotechnology Co.,Ltd.
Shanghai Yaxin Biotechnology Co.,Ltd.
Manufacturer from China
Shanghai Yaxin Biotechnology Co.,Ltd.
Shanghai Yaxin Biotechnology Co.,Ltd.
Shanghai Yaxin Biotechnology Co., Ltd. was founded in 2008, which is a high-tech enterprise that focuses on researching and producing the recombinant proteins.YaxinBio is the first and only company on researching and producing the recombinant carboxypeptidase B and recombinant trypsin. Animal-origin-free enzymes are specially used in the human recombinant insulin production, and exporting abroad.
Recombinant trypsin is used in the cell culturing process,which conforms to the 2014 USP on the usage of trypsin in the cell culture and the 2020 CP. Animal-origin-free is very important for the production of antibody and vaccine.Usage of recombinat trypsin fundamentally solves the problem of animal original virus contamination in the human recombinant insulin production.
YaxinBio insists on “scientific and technological innovation”, has developed with independent intellectual property rights of the products.YaxinBio obtained the support of Chinese ministry of science and technology and Shanghai innovation fund project in 2010; The products recombinant trypsin, recombinant carboxypeptidase B and recombinant protein A won the Shanghai high-tech achievement transformation project in Sep.2013.
Shanghai Yaxin Biotechnology Co., Ltd. has the ability to produce and supply high-purity and high-activity biological products, together with complete supervision services, making the company the preferred supplier of many leading international biopharmaceutical companies.
| Company Name: | Shanghai Yaxin Biotechnology Co.,Ltd. |
|---|---|
| Business Type: | Manufacturer,Exporter,Seller |
| Brands: | YAXINBIO |
| Employee Number: | 20~50 |
| Year Established: | 2008 |
| Total Sales Annual: | 50000-100000 |
| Company Location: | No.466 YinDu Road,XuHui, Shanghai, China |
| Factory Location: | No.466 YinDu Road,XuHui, Shanghai, China |
Shanghai Yaxin Biotechnology Co.,Ltd.
Shanghai Yaxin Biotechnology Co.,Ltd. was established in 2008, is a dedicated manufacturer in the fields of recombinant enzymes expressed with E. Coli system in China. The company supplies only the best quality products at competitive prices to customers worldwide, and through cooperation with pharmaceutical and biotechnology companies, Yaxin Biotechnology Ltd is continously developing the seriers products. Both recombinant trypsin and recombinant carboxypeptidase B, with highest selectivity and special activity, are specially applied in the field of recombinant insulin and insulin analogues manufacturing by our customers worldwide.
Recombinant trypsin is conformed to USP 2015 standard ”Enzymes used as ancillary material in pharmaceutical manufacturing—recombinant trypsin”, which is used in the cell culturing. And recombinant aprotinin (trypsin inhibitor, BPTI) is another product in the cell culture field.
YaxinBio insists on "scientific and technological innovation", owned independent intellectual property rights of the products. The main products are: recombinant human trypsin (PRSS, RHT), recombinant porcine trypsin (RPT), recombinant carboxypeptidase B, recombinant protein A, recombinant chymotrypsin, recombinant enterokinase, recombinant aprotinin (trypsin inhibitor, BPTI), V8, et al.
We set our enterprise goal as----to be a professional manufacturer of recombinant enzymes, serves the pharmaceutical manufacturers in the world.
Research and development department
Marketing Department
History of YaxinBio
（1）Established in 2008. Dr Suxia Li as founder and technical expert
（2）In 2009, the first product, recombinant carboxypeptidase B (rCPB) was successful in market.
（3）In 2010, both rCPB and rTrypsin gained full success and used in r-insulin production process in China and exported to Europe and India.
（4）In 2012, recombinant Protein A, got success in market.
（5）In 2013, gained certificate of NSF ISO9001:2008.
（6）In 2014, recombinant Enterokinase lauched.
（7）In 2015, recombinant Aprotinin; and sequencing grade rTrypsin and rCPB; woned Shanghai high-tech Incorporation.
（8）In 2016, recombinant chymotrypsin and recombinant V8 (endoproteinase Glu-C) and Kex 2 succeed.
（9）In 2017, improve ICH quality system
（10）In 2020, Recombinant Trypsin Quality Standard of 2020 Chinese Pharmacopoeia
Product List
Sequencing Grade Carboxypeptidase B
Recombinant Porcine Trypsin
Recombinant Carboxypeptidase B
Recombinant Human Trypsin
Recombinant Enterokinase
Protein A affinity media
Sequencing Grade Modified Recombinant Trypsin
recombinant trypsin
recombinant protein A
recombinant enterokinase
recombinant aprotinin
Recombinant Kex2 Protease
V8（Endoproteinase Glu-C)
Recombinant Carboxypeptidase B ELISA Kit
Recombinant Trypsin ELISA Kit
Recombinant Enterokinase ELISA Kit
Recombinant Kex2 Protease ELISA Kit
Super Nuclease
| Market name: | North America,South America,Western Europe,Eastern Europe,Eastern Asia,Southeast Asia,Middle East,Africa |
|---|---|
| Contact Person: | zhao |